AVIR
Atea Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.39
+1.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 53.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.72x
- Price / sales
- —
- Price / cash flow
- -2.32x
Enterprise value
- Enterprise value
- $133.1M
- EV / sales
- —
- EV / EBITDA
- -0.78x
- EV / EBIT
- -0.72x
- Market cap
- $352.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026